The European Lung Cancer Surgery Market size is expected to grow at a CAGR of 6.2% from 2022 to 2027. The value of the market is forecasted to grow USD 9.53 billion by 2027, from USD 7.05 billion in 2022.
Cancer is generally defined by the name of the part in which it starts. Lung Cancer is a Cancer that starts in Bronchus, lung Tissue, or Trachea. They are many ways to treat Lung Cancer like Radiotherapy, Chemotherapy, Laser therapy, and Surgery. Surgery involves the removal of the infected sections from the lungs. But Surgery can only be used if cancer cells don’t spread very near to the heart.
Rising pollution levels, an increasing number of cigarette smokers, rising incidence and prevalence of Lung Cancer, and rising geriatric population are major factors driving the market.
However, the high cost of Lung Cancer surgery is restraining the growth of the market.
This research report on the European Lung Cancer Surgery Market has been segmented & sub-segmented into the following categories:
Based on procedure, Minimally Invasive surgeries are expected to grow at the highest CAGR owing to the rising awareness among people for early detection of lung cancer and the advantages of Minimally Invasive Surgeries over conventional surgeries.
Based on the device, the Surgical Instruments segment is expected to dominate the market due to the shorter lifespan of devices and the wider adoption of these devices.
Geographically, Europe has the second-largest market after North America owing to its Advanced Healthcare facilities and higher awareness among people, and greater economic stability.
Promising companies leading the European Lung Cancer Surgery Market include Ethicon US LLC, Intuitive Surgical Inc., AngioDynamics Inc., Olympus Corporation, Accuray Inc., Ackermann Instrumente GmbH, Teleflex Inc., KARL STORZ GmbH, Scanlan International Inc., and Trokamed GmbH.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
18.104.22.168 Sleeve Resection
5.1.3 Minimally Invasive
5.1.4 Y-o-Y Growth Analysis, By Procedure
5.1.5 Market Attractiveness Analysis, By Procedure
5.1.6 Market Share Analysis, By Procedure
5.2.2 Surgical Devices
22.214.171.124 RIB Sheers
5.2.3 Monitoring Devices
126.96.36.199 Cameras & Video Support
5.2.4 Visualizing Devices
188.8.131.52 Endoscopic Trocars with optical views
184.108.40.206 Endo surgical Equipment
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Procedure
22.214.171.124 By Device
6.1.4 Market Attractiveness Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Procedure
184.108.40.206 By Device
6.1.5 Market Share Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Procedure
22.214.171.124 By Device
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Ethicon US LLC
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Intuitive Surgical Inc.
8.3 Olympus Corporation
8.4 Accuray Inc.
8.5 AngioDynamics Inc.
8.6 Teleflex Inc.
8.7 KARL STORZ GmbH
8.8 Ackermann Instrumente GmbH
8.9 Scanlan International Inc.
8.10 Trokamed GmbH.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.